As for the future, Mojsov is optimistic. She foresees a new generation of similar drugs that will further minimize side effects and target an even broader range of diseases.
Proposal submitted for FDA 505(b)(2) regulatory pathway for SPC-15 approvalAdvancing path to IND submission for first-in-human trialsSARASOTA, ...
As for the future, Mojsov is optimistic. She foresees a new generation of similar drugs that will further minimize side effects and target an even broader range of diseases.
Half a century of advancements in biomedical science paved the way for today's powerful weight-loss drugs like Ozempic -- so what was that journey like for the scientists involved? Joel Habener of ...
Half a century of advancements in biomedical science paved the way for today's powerful weight-loss drugs like Ozempic ... Habener believed he could uncover new ways to manage diabetes.